Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

FHL2 antibody

FHL2 Reactivity: Human WB Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN2763848
  • Target See all FHL2 Antibodies
    FHL2 (Four and A Half LIM Domains 2 (FHL2))
    Reactivity
    • 44
    • 31
    • 17
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Host
    • 35
    • 8
    • 2
    Rabbit
    Clonality
    • 29
    • 15
    Polyclonal
    Conjugate
    • 27
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    This FHL2 antibody is un-conjugated
    Application
    • 26
    • 11
    • 9
    • 9
    • 6
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Cross-Reactivity
    Human
    Characteristics
    Four-and-a-half LIM only protein 2, FHL2,Sphingosine kinase-1 (SK1) is a key enzyme that catalyzes the phosphorylation of sphingosine to sphingosine-1-phosphate (S1P). SK1, and its product S1P, regulate numerous and diverse biological functions, including cell growth, differentiation, proliferation, and apoptosis. S1P also plays a central role in cardiac development and ischemic preconditioning. FHL2 (SLIM3) has been identified as a SK1-interacting protein in mammalian cardiomyocytes. FHL2, but not FHL1 or FHL3, interacts with SK1, and FHL2 colocalizes with SK1 in the cytoplasm of these cells. The interaction of FHL2 with SK-1 involves the C-terminal portion of SK1. Overexpression of FHL2 has been found to attneuate the activity and antiapoptotic effects of SK1. Endothelin-1, a potent survival factor in cardiomyocytes, inhibits FHL2-SK1 association and increases SK1 activity. FHL2 is therefore a novel inhibitor of SK1 activity in cardiomyocytes and targeting FHL2 may prevent myocardial apoptosis through activation of SK1. A transcriptional coactivator, FHL2 is also known to form complexes consisting of Proline-, glutamic acid-, and leucine-rich protein-1 (PELP1), FHL2, and androgen receptors (AR) in prostate cancer cells, perhaps functioning as a molecular adaptor with PELP1 in the progression of prostate cancer.
    Purification
    Antigen Immunoaffiinity Purification
    Immunogen
    Synthetic peptide derived from the human FHL2 protein
    Isotype
    IgG
    Top Product
    Discover our top product FHL2 Primary Antibody
  • Application Notes
    Antibody can be used for Western blotting (0.5-2 μg/mL). Also binds ABB73038, FHL2 isoform 5 with MW of 389 a.a. (~42 kDa). Optimal concentration should be evaluated by serial dilutions.
    Restrictions
    For Research Use only
  • Concentration
    Lot specific
    Buffer
    Provided as ligand affinity purified antibody in phosphate buffered saline with 0.08 % sodium azide
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -80 °C
    Storage Comment
    Product should be stored at -70°C. Aliquot to avoid freeze/thaw cycles
  • Target
    FHL2 (Four and A Half LIM Domains 2 (FHL2))
    Alternative Name
    FHL2 (FHL2 Products)
    Synonyms
    AAG11 antibody, DRAL antibody, FHL-2 antibody, SLIM-3 antibody, SLIM3 antibody, C76204 antibody, FHL2 antibody, zgc:92428 antibody, zgc:103466 antibody, four and a half LIM domains 2 antibody, four and a half LIM domains 2a antibody, four and a half LIM domains 2b antibody, FHL2 antibody, Fhl2 antibody, fhl2 antibody, fhl2a antibody, fhl2b antibody
    Pathways
    Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Lipid Metabolism by PPARalpha
Support